发明名称 ORAL FORMULATION
摘要 An orally administering formulation is provided to be able to inhibit wetting, solidification and coloration change and be stable without the combination change even through ibuprofen and an antacid are contained in one granule, and be convenient for preparation with decreased manufacturing cost. An orally administering formulation is obtained by wet-granulating a composition comprising ibuprofen, an antacid, a swelling agent, wherein the antacid is magnesium oxide or sodium hydrogen carbonate, and the swelling agent is at least one selected from the group consisting of lowly substituted hydroxypropylcellulose, carmellose or a salt thereof, croscarmellose sodium, carboxymethyl starch sodium, crospovidone and crystalline cellulose.carmellose sodium.
申请公布号 KR101288924(B1) 申请公布日期 2013.07.24
申请号 KR20060076995 申请日期 2006.08.16
申请人 发明人
分类号 A61K9/20;A61K31/19;A61K31/192 主分类号 A61K9/20
代理机构 代理人
主权项
地址